Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...

Cognitive Development During Adulthood

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...

Aging

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...

Alzheimer Disease l: Introduction

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...

Alzheimer Disease ll: Pathophysiology

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...

Dementia l: Introduction

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Numerical optimization of Rb<sub>2</sub>AuScBr<sub>6</sub> and Rb<sub>2</sub>AuScCl<sub>6</sub>-based lead-free perovskite solar cells: device engineering and performance mapping.

RSC advances·2025

Same author

Assessing the identifiability of model selection frameworks for the prediction of patient outcomes in the clinical breast cancer setting.

Journal of computational science·2025

Same author

Iodinated Contrast Induced Parotitis: A Case Report.

Mymensingh medical journal : MMJ·2024

Same author

Electron removal from H<sub>2</sub>O by hydrogen-like projectile impact.

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine·2022

Same author

Few UK vascular centres offer a fully NICE-compliant supervised exercise programme: a national audit.

Annals of the Royal College of Surgeons of England·2022

Same author

Few UK vascular centres offer a fully NICE-compliant supervised exercise programme: a national audit.

Annals of the Royal College of Surgeons of England·2021

Search research articles

Related Experiment Video

Updated: Jul 16, 2026

Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach

Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach

Published on: February 14, 2014

XE-CT CBF changes during normative aging, cognitive decline and dementia.

J S Meyer¹, G M Rauch, R A Rauch

¹Cerebrovascular Research Laboratories, Veterans Administration Medical Center, Houston, TX, USA.

The Keio Journal of Medicine

|April 6, 2000

Summary

Certain lifestyle factors like hypertension and smoking accelerate cognitive decline and dementia. Managing these risks may help preserve brain health and cognitive function.

More Related Videos

A Method for Investigating Age-related Differences in the Functional Connectivity of Cognitive Control Networks Associated with Dimensional Change Card Sort Performance

A Method for Investigating Age-related Differences in the Functional Connectivity of Cognitive Control Networks Associated with Dimensional Change Card Sort Performance

Published on: May 7, 2014

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

Published on: January 24, 2020

Related Experiment Videos

Last Updated: Jul 16, 2026

Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach

Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach

Published on: February 14, 2014

A Method for Investigating Age-related Differences in the Functional Connectivity of Cognitive Control Networks Associated with Dimensional Change Card Sort Performance

A Method for Investigating Age-related Differences in the Functional Connectivity of Cognitive Control Networks Associated with Dimensional Change Card Sort Performance

Published on: May 7, 2014

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

Published on: January 24, 2020

Area of Science:

Neurology
Gerontology
Public Health

Background:

Cerebral degenerative changes are linked to cognitive decline and dementia.
Identifying modifiable risk factors is crucial for preventative strategies.

Purpose of the Study:

To investigate the correlation between putative risk factors and indicators of cerebral degeneration.
To assess the impact of these factors on cognitive decline and dementia progression.

Main Methods:

Correlational analysis of risk factors with repeated measures of cerebral atrophy, CT densitometry, and perfusions.
Cognitive testing in neurologically and cognitively normative volunteers.

Main Results:

Transient ischemic attacks (TIAs), hypertension, smoking, and male gender were identified as factors accelerating cerebral degenerative changes.
These factors also accelerated mild cognitive decline and dementia.

Conclusions:

Intervention strategies targeting modifiable risk factors, alongside cholinesterase inhibitors, may prevent atropho-degenerative changes.
Preventative measures can help maintain optimal cognitive performance.